Leukemia cells were obtained from the peripheral blood (PB) of AML patients who had a blast population of more than 80% in their PB at diagnosis before chemotherapy (Supplementary Table 2). After ...
Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: A comparative study with histology, proangiogenic cytokines and clinical markers This is an ASCO Meeting Abstract ...
The efficacy and safety of CD52 antibody alemtuzumab to treat severe acute GVHD in 18 consecutive patients refractory to standard high-dose corticosteroid therapy is reported. Patients (age range ...
Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia. Twenty-nine patients who had relapsed after an initial response (n = 8) or were refractory (n ...
PARIS, May 11, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – Euronext Growth: ALCLS), a clinical-stage biotechnological company employing its core proprietary technologies to develop best-in ...
BASEL, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cimeio Therapeutics, a biotechnology company leading the field of epitope shielding, is presenting data for its CD52 program during this week’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results